(TBI) TrueBlue - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US89785X1019
TBI EPS (Earnings per Share)
TBI Revenue
TBI: Contingent Staffing, Recruitment Outsourcing, Workforce Management
TrueBlue Inc. (NYSE:TBI) is a leading provider of specialized workforce solutions across North America, the UK, Australia, and Puerto Rico, operating through three distinct business segments: PeopleReady, PeopleManagement, and PeopleScout. PeopleReady offers contingent staffing services for various industries, including construction, transportation, and manufacturing. PeopleManagement provides on-site industrial staffing and commercial driver services, managing contingent workforces for manufacturing, warehousing, and distribution facilities. PeopleScout delivers recruitment process outsourcing, talent advisory services, and managed service provider solutions, leveraging its proprietary technology platform, Affinix, to source, screen, and onboard talent.
The companys diversified service offerings enable it to cater to a broad range of clients, from construction and transportation to manufacturing and retail. With a history dating back to 1985, TrueBlue has evolved from its origins as Labor Ready, Inc. to become a comprehensive workforce solutions provider. Its expertise in contingent staffing, recruitment process outsourcing, and talent advisory services positions it to capitalize on the growing demand for flexible workforce solutions.
Analyzing the provided
From a fundamental perspective, TrueBlues
Combining the insights from both technical and fundamental data, a potential forecast for TrueBlue Inc. could be that the stock may continue to experience volatility in the short term, potentially trading within the range of $4 to $6. However, the long-term outlook remains uncertain due to the companys negative RoE and high forward P/E ratio. To achieve a more accurate forecast, it is essential to closely monitor the companys future earnings reports, industry trends, and overall market conditions. A potential trading strategy could involve buying TBI on dips towards its SMA20 or SMA50, with a stop-loss below the recent lows, targeting a potential upside towards $7-$8, aligning with its 200-day SMA. Nonetheless, this strategy requires continuous monitoring and adjustments based on new information and market dynamics.
Additional Sources for TBI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
TBI Stock Overview
Market Cap in USD | 202m |
Sector | Industrials |
Industry | Staffing & Employment Services |
GiC Sub-Industry | Human Resource & Employment Services |
IPO / Inception | 1996-06-13 |
TBI Stock Ratings
Growth Rating | -71.3 |
Fundamental | -62.4 |
Dividend Rating | 0.0 |
Rel. Strength | -47.5 |
Analysts | 4 of 5 |
Fair Price Momentum | 5.35 USD |
Fair Price DCF | - |
TBI Dividends
Currently no dividends paidTBI Growth Ratios
Growth Correlation 3m | 71.5% |
Growth Correlation 12m | -77.7% |
Growth Correlation 5y | -76.4% |
CAGR 5y | -15.69% |
CAGR/Max DD 5y | -0.18 |
Sharpe Ratio 12m | 0.40 |
Alpha | -47.28 |
Beta | 0.684 |
Volatility | 59.92% |
Current Volume | 251k |
Average Volume 20d | 200.9k |
As of June 26, 2025, the stock is trading at USD 6.42 with a total of 251,026 shares traded.
Over the past week, the price has changed by -9.32%, over one month by +4.90%, over three months by +13.83% and over the past year by -37.18%.
No, based on ValueRay´s Fundamental Analyses, TrueBlue (NYSE:TBI) is currently (June 2025) a stock to sell. It has a ValueRay Fundamental Rating of -62.37 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TBI is around 5.35 USD . This means that TBI is currently overvalued and has a potential downside of -16.67%.
TrueBlue has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy TBI.
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, TBI TrueBlue will be worth about 5.9 in June 2026. The stock is currently trading at 6.42. This means that the stock has a potential downside of -7.79%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 8.3 | 29.8% |
Analysts Target Price | 8.3 | 29.8% |
ValueRay Target Price | 5.9 | -7.8% |